Archon Capital Management’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.3M | Sell |
2,790,923
-422,303
| -13% | -$1.58M | 5.81% | 2 |
|
|
2025
Q4 | $11.2M | Sell |
3,213,226
-68,260
| -2% | -$238K | 6.4% | 2 |
|
|
2025
Q3 | $7.02M | Hold |
3,281,486
| – | – | 4.18% | 6 |
|
|
2025
Q2 | $7.38M | Sell |
3,281,486
-15,258
| -0.5% | -$21.5K | 6.05% | 2 |
|
|
2025
Q1 | $4.52M | Buy |
3,296,744
+156,463
| +5% | +$216K | 4.76% | 4 |
|
|
2024
Q4 | $4.96M | Buy |
3,140,281
+25,000
| +0.8% | +$35K | 5.97% | 5 |
|
|
2024
Q3 | $3.86M | Hold |
3,115,281
| – | – | 7.24% | 4 |
|
|
2024
Q2 | $4.17M | Sell |
3,115,281
-336,749
| -10% | -$497K | 4.85% | 11 |
|
|
2024
Q1 | $4.69M | Hold |
3,452,030
| – | – | 2.22% | 24 |
|
|
2023
Q4 | $9.04M | Hold |
3,452,030
| – | – | 3.72% | 17 |
|
|
2023
Q3 | $11M | Hold |
3,452,030
| – | – | 4.95% | 9 |
|
|
2023
Q2 | $17.4M | Hold |
3,452,030
| – | – | 6.3% | 7 |
|
|
2023
Q1 | $9.94M | Hold |
3,452,030
| – | – | 3.52% | 16 |
|
|
2022
Q4 | $8.08M | Buy |
3,452,030
+757,781
| +28% | +$2.31M | 3.11% | 19 |
|
|
2022
Q3 | $12.1M | Buy |
2,694,249
+31,336
| +1% | +$224K | 5% | 11 |
|
|
2022
Q2 | $15.6M | Buy |
2,662,913
+329,324
| +14% | +$1.69M | 5.59% | 7 |
|
|
2022
Q1 | $15.2M | Buy |
2,333,589
+139,471
| +6% | +$1.37M | 3.94% | 16 |
|
|
2021
Q4 | $28.1M | Sell |
2,194,118
-44,397
| -2% | -$621K | 6.32% | 8 |
|
|
2021
Q3 | $31M | Sell |
2,238,515
-210,887
| -9% | -$2.22M | 6.55% | 10 |
|
|
2021
Q2 | $25.3M | Hold |
2,449,402
| – | – | 5.38% | 8 |
|
|
2021
Q1 | $23.7M | Sell |
2,449,402
-52,675
| -2% | -$527K | 5.6% | 9 |
|
|
2020
Q4 | $18M | Hold |
2,502,077
| – | – | 4.67% | 10 |
|
|
2020
Q3 | $11.8M | Buy |
2,502,077
+19,195
| +0.8% | +$95.1K | 4.13% | 10 |
|
|
2020
Q2 | $13.8M | Sell |
2,482,882
-112,000
| -4% | -$465K | 4.98% | 7 |
|
|
2020
Q1 | $9.32M | Sell |
2,594,882
-95,144
| -4% | -$639K | 5.25% | 7 |
|
|
2019
Q4 | $22.8M | Sell |
2,690,026
-50,000
| -2% | -$361K | 8.59% | 5 |
|
|
2019
Q3 | $18.6M | Sell |
2,740,026
-54,400
| -2% | -$386K | 7.67% | 6 |
|
|
2019
Q2 | $18.8M | Buy |
2,794,426
+1,267,754
| +83% | +$6.89M | 6.76% | 7 |
|
|
2019
Q1 | $9.63M | Sell |
1,526,672
-453,038
| -23% | -$3.5M | 3.94% | 12 |
|
|
2018
Q4 | $12.8M | Sell |
1,979,710
-44,300
| -2% | -$268K | 6.83% | 6 |
|
|
2018
Q3 | $14.4M | Sell |
2,024,010
-242,028
| -11% | -$1.35M | 7.61% | 6 |
|
|
2018
Q2 | $9.86M | Hold |
2,266,038
| – | – | 5.64% | 9 |
|
|
2018
Q1 | $6.73M | Buy |
2,266,038
+57,500
| +3% | +$148K | 5.5% | 9 |
|
|
2017
Q4 | $5.74M | Buy |
2,208,538
+2,133,462
| +2,842% | +$6.66M | 4.6% | 13 |
|
|
2017
Q3 | $254K | Buy |
+75,076
| New | +$194K | 0.2% | 25 |
|
Other funds holding APYX
NCM
RA
VCM
ACM
SBCM
EIM
HKAM
